Exact Mass: 387.0466142
Exact Mass Matches: 387.0466142
Found 116 metabolites which its exact mass value is equals to given mass value 387.0466142,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Thifensulfuron-methyl
C12H13N5O6S2 (387.03072380000003)
CONFIDENCE standard compound; EAWAG_UCHEM_ID 124 CONFIDENCE standard compound; INTERNAL_ID 3688
dCDP
dCDP is a substrate for Uridine-cytidine kinase 1, Nucleoside diphosphate kinase (mitochondrial), Nucleoside diphosphate kinase homolog 5, Ribonucleoside-diphosphate reductase large subunit, Nucleoside diphosphate kinase A, Nucleoside diphosphate kinase 7, Ribonucleoside-diphosphate reductase M2 chain, Nucleoside diphosphate kinase B, Nucleoside diphosphate kinase 3, Nucleoside diphosphate kinase 6 and UMP-CMP kinase. [HMDB]. dCDP is found in many foods, some of which are oil palm, sweet bay, garden onion (variety), and italian sweet red pepper. dCDP is a substrate for Uridine-cytidine kinase 1, Nucleoside diphosphate kinase (mitochondrial), Nucleoside diphosphate kinase homolog 5, Ribonucleoside-diphosphate reductase large subunit, Nucleoside diphosphate kinase A, Nucleoside diphosphate kinase 7, Ribonucleoside-diphosphate reductase M2 chain, Nucleoside diphosphate kinase B, Nucleoside diphosphate kinase 3, Nucleoside diphosphate kinase 6 and UMP-CMP kinase. Acquisition and generation of the data is financially supported in part by CREST/JST.
Glucobrassicanapin
Isolated from rape (Brassica napus) and other Brassica species Glucobrassicanapin is found in many foods, some of which are swede, chinese mustard, chinese cabbage, and horseradish. Glucobrassicanapin is found in brassicas. Glucobrassicanapin is isolated from rape (Brassica napus) and other Brassica sp.
benzylhydrochlorothiazide
C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49185 - Thiazide Diuretic Same as: D01246
1-Pentenyl glucosinolate
1-Pentenyl glucosinolate is found in brassicas. 1-Pentenyl glucosinolate is present in brassica Present in brassicas. 1-Pentenyl glucosinolate is found in brassicas.
3',4'-Dichlorobenzamil
C13H12Cl3N7O (387.01688720000004)
2-Amino-5-[[1-[carboxymethyl(sulfo)amino]-1-oxo-3-sulfanylpropan-2-yl]amino]-5-oxopentanoic acid
4-[4-(Quinolin-2-ylmethoxy)phenyl]sulfanylbenzoic Acid
2-{2-[3,5-Bis(trifluoromethyl)phenyl]hydrazono}-2-(propylsulfonyl)acetonitrile
O1-(3-benzoxazol-2-yl-phenyl)-beta(?)-D-glucopyranuronic acid|O1-(3-Benzoxazol-2-yl-phenyl)-beta(?)-D-glucopyranuronsaeure
(+)-3-chloro-N-formylnornantenine
C20H18ClNO5 (387.08734480000004)
glutathioselenol
A glutathione derivative that is glutathione in which the hydrogen attached to the sulfur is replaced by a selenol group.
1-Pentenyl glucosinolate
Thiazolidine, 2-(4-methylphenyl)-3-[[3-(trifluoromethyl)phenyl]sulfonyl]- (9CI)
5-bromo-3-[5-(morpholin-4-ylmethyl)-1H-pyridin-2-ylidene]-1H-indol-2-one
Amoxicillin sodium
C16H18N3NaO5S (387.08648180000006)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
N-[1-(5-chloro-2,3-dimethoxyphenyl)ethyl]-5-fluoro-2-methylsulfonylaniline
C17H19ClFNO4S (387.07072960000005)
6-BROMO-2-(2,4-DIMETHOXYPHENYL)QUINOLINE-4-CARBOXYLICACID
C18H14BrNO4 (387.01061440000007)
4-(1,5-DIMETHYL-3-OXO-2-PHENYL-2,3-DIHYDRO-1H-PYRAZOL-4-YLSULFAMOYL)-BENZOIC ACID
C18H17N3O5S (387.08888720000004)
Benzenesulfonamide,N-(2,4-dinitro-1-naphthalenyl)-4-methyl-
C17H13N3O6S (387.05250380000007)
3-BOC-2-(4-BROMO-PHENYL)-THIAZOLIDINE-4-CARBOXYLIC ACID
C15H18BrNO4S (387.01398480000006)
Ethylenediaminetetraacetate-copper-ammonia complex
3-Bromo-N,N-dipropyl-5-(trifluoromethyl)benzenesulfonamide
C13H17BrF3NO2S (387.01153980000004)
[3-(4-BROMOPHENYL)-3-OXOPROP-1-ENYL](TRIPROPYL)AMMONIUM CHLORIDE
7,8-Dimethoxy-3-(3-iodopropyl)-1,3-dihydro-2H-3-benzazepin-2-one
C15H18INO3 (387.0331388000001)
Benzenesulfonylchloride, 4-[2-[(5-chloro-2-methoxybenzoyl)amino]ethyl]-
C16H15Cl2NO4S (387.00988100000006)
O-[3-chloro-4-(diethylsulfamoyl)phenyl] O,O-dimethyl phosphorothioate
4-Oxo-2-phenyl-4H-chromen-3-yl 4-nitrobenzoate
C22H13NO6 (387.07428380000005)
4-[4-Bromo-3-[[(tetrahydro-2H-pyran-2-yl)oxy]methyl]phenoxy]benzonitrile
2-(4-Bromophenyl)-4,6-diphenyl-1,3,5-triazine
C21H14BrN3 (387.03710240000004)
2-(3-Bromophenyl)-4,6-diphenyl-1,3,5-triazine
C21H14BrN3 (387.03710240000004)
IMidazo[1,2-d][1,4]benzoxazepine, 9-bromo-5,6-dihydro-2-[3-Methyl-1-(1-Methylethyl)-1H-1,2,4-triazol-5-yl]-
Bromotris(dimethylamino)phosphonium hexafluorophosphate
C6H18BrF6N3P2 (387.00634599999995)
4-(4-Bromphenyl)-2,2:6,2-terpyridin
C21H14BrN3 (387.03710240000004)
3-Bromo-N-hexyl-5-(trifluoromethyl)benzenesulfonamide
C13H17BrF3NO2S (387.01153980000004)
6-[(3-Methoxyphenyl)methyl]-4-methyl-2-methylsulfinyl-5-thieno[3,4]pyrrolo[1,3-d]pyridazinone
C18H17N3O3S2 (387.07112920000003)
2,4-dichloro-N-[5-(5,6,7,8-tetrahydronaphthalen-2-yl)-1,3,4-oxadiazol-2-yl]benzamide
3-(benzenesulfonyl)-2-hydroxy-2-methyl-N-[3-(trifluoromethyl)phenyl]propanamide
C17H16F3NO4S (387.0752092000001)
5-(1H-benzimidazol-2-ylmethylidene)-3-(2-naphthalenyl)-2-sulfanylidene-4-thiazolidinone
2,3-Dihydroxybutanedioic acid--3-(5-nitrofuran-2-yl)-5,6-dihydroimidazo[2,1-b][1,3]thiazole (1/1)
C13H13N3O9S (387.03724880000004)
(2S,4E)-4-[2-[(1S)-1-carboxylato-2-(3,4-dihydroxyphenyl)ethyl]iminoethylidene]-2,3-dihydro-1H-pyridine-2,6-dicarboxylate
(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(6-oxobenzo[c]chromen-3-yl)oxyoxane-2-carboxylate
[(2R,3S,4R,5S)-5-(2-amino-5-cyano-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-7-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate
C12H14N5O8P (387.05799740000003)
Glucobrassicanapin
An alkenylglucosinolic acid that consists of 1-thio-beta-D-glucopyranose having a 6-[(sulfooxy)imino]hex-1-en-6-yl group attached to the anomeric sulfur.
N-(4-bromo-2-methylphenyl)-3-(1,3-dioxo-2-pyrrolo[3,4-c]pyridinyl)propanamide
C17H14BrN3O3 (387.02184740000007)
3,5-diamino-N-[amino-[(2,4-dichlorophenyl)methylimino]methyl]-6-chloro-2-pyrazinecarboxamide
C13H12Cl3N7O (387.01688720000004)
5-(2,5-dichlorophenyl)-N-(2,6-diethylphenyl)-2-furancarboxamide
2-[(2,4-dichlorophenoxy)acetyl]-N-(4-fluorophenyl)hydrazinecarbothioamide
1-(2-furanylmethyl)-N-[2-(methylthio)-1,3-benzothiazol-6-yl]-5-oxo-3-pyrrolidinecarboxamide
C18H17N3O3S2 (387.07112920000003)
N-{3-[3-(5-bromo-2-methoxyphenyl)acryloyl]phenyl}propanamide
1-(2-Chlorophenyl)-3-[[(1-ethyl-2-methyl-5-benzimidazolyl)-oxomethyl]amino]thiourea
C18H18ClN5OS (387.09205280000003)
4-chloro-2-(5-methyl-1,3-dioxooctahydro-2H-isoindol-2-yl)phenyl 2-furoate
C20H18ClNO5 (387.08734480000004)
[(3aR,4R,9bR)-8-bromo-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-(2-pyridinyl)methanone
[(3aS,4S,9bS)-8-bromo-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-(2-pyridinyl)methanone
[(3aR,4S,9bR)-8-bromo-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-(2-pyridinyl)methanone
[(3aS,4R,9bS)-8-bromo-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-(2-pyridinyl)methanone
O-(N-acetylglucosamine-1-phosphonatooxy)-L-serine(1-)
C11H20N2O11P- (387.08046800000005)
[5-[2-amino-5-(methylaminomethyl)-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-7-yl]-3-hydroxy-2,5-dihydrofuran-2-yl]methyl dihydrogen phosphate
[5-(2-amino-5-carbamoyl-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-7-yl)-3-hydroxy-2,5-dihydrofuran-2-yl]methyl dihydrogen phosphate
C12H14N5O8P (387.05799740000003)
Deoxycytidine diphosphate
A 2-deoxycytidine phosphate that is the 2- deoxy derivative of cytidine 5-diphosphate (CDP).
CCMI
CCMI (AVL-3288) is a potent and selective α7 nAChR-positive allosteric modulator, does not bind to or activate α7 nAChRs via the orthosteric site, and causes significant positive modulation of agonist-induced currents at α7 nAChRs. CCMI has potential in CNS diseases with cognitive dysfunction[1].
ERK5-IN-2
ERK5-IN-2 is an orally active, sub-micromolar, selective ERK5 inhibitor with IC50s of 0.82 μM, 3 μM for ERK5 and ERK5 MEF2D, respectively. ERK5-IN-2 does not interact with the BRD4 bromodomain. ERK5-IN-2 suppresses both tumor xenograft growth and basic fibroblast growth factor (bFGF) driven Matrigel plug angiogenesis[1].
VU0650786
VU0650786 is a potent and selective CNS penetrant negative allosteric modulator of metabotropic glutamate receptor subtype 3 (mGlu3 NAM), with an IC50 of 392 nM. VU0650786 has antidepressant and anxiolytic activity in rodents[1].
(12s)-17-chloro-18,19-dimethoxy-5,7-dioxa-13-azapentacyclo[10.7.1.0²,¹⁰.0⁴,⁸.0¹⁶,²⁰]icosa-1(19),2,4(8),9,16(20),17-hexaene-13-carbaldehyde
C20H18ClNO5 (387.08734480000004)
[(z)-(1-{[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}hex-5-en-1-ylidene)amino]oxysulfonic acid
[6-hydroxy-3-(6-hydroxy-1h-indol-3-yl)-9h-pyrido[3,4-b]indol-4-yl](oxo)acetic acid
C21H13N3O5 (387.08551680000005)
17-chloro-18,19-dimethoxy-5,7-dioxa-13-azapentacyclo[10.7.1.0²,¹⁰.0⁴,⁸.0¹⁶,²⁰]icosa-1(19),2,4(8),9,16(20),17-hexaene-13-carbaldehyde
C20H18ClNO5 (387.08734480000004)